Navigation

Collaborative Research Centres

Collaborative Research Centres at FAU

Collaborative Research Centres (CRCs) and Transregios (TRs) are research institutions at universities which are awarded long-term funding where researchers work together as part of an interdisciplinary research programme. FAU is currently involved in 12 CRCs/TRs and is the coordinating university for eight of these projects.

Collaborative Research Centres coordinated by FAU

Additive manufacturing describes production technologies which construct components in layers according to a computer model. In the future, it will be possible to produce plastic and metal components directly from a computer at the click of a mouse, very much like printing on paper today. CRC 814 concentrates on the fundamental questions surrounding this promising technology. A better understanding of how powder behaves during production will be used to manufacture new and improved powder materials, and optimise machine design and processes.

Go to website

Synthetic carbon allotropes such as fullerenes, carbon nanotubes and graphenes are one of the most promising families of materials today. Due to their unique electrical, optical, mechanical and chemical properties, they have a great deal of potential for high-performance applications in areas of nanoelectronics and optoelectronics, in hydrogen storage, in sensors, and in polymer strengthening.

Go to website

Inflammation is an important repair mechanism that activates the body’s immune cells in order to respond to tissue stress and damage. CRC 1181 aims to gain a better understanding of the molecular processes involved in stopping this immune response after repairs have been completed. This is important as immune cells that are not deactivated continue to act on healthy tissue, leading to chronic inflammation which is manifested as conditions such as asthma or arthritis. Researchers at CRC 1181 are investigating fundamental immune mechanisms, the activation of defence cells, and the relationship between tissue structure and cell death in order to find out why the immune response is not deactivated in the case of chronic inflammation.

Go to website

The goal of CRC/TR 73 is to optimise components made of sheet metal. One aspect of research is how the functionality and complexity of sheet metal can be increased. The second research focus is developing new, robust and flexible manufacturing processes in the first ever attempt to combine sheet metal forming processes with processes used in bulk metal forming. This should make it possible to produce integrated components which have fewer individual parts, as well as high-performance and lightweight components which can be produced in both large and small quantities.

Go to website

The key innovative idea behind invasive computing is to introduce resource-aware programming support. This means that a programme can dynamically distribute its computing processes to neighbouring processors, in a process similar to a phase of invasion. Code with a high degree of parallelism is then run in parallel through the available (invasible) parts of the multi-processor architecture.

Go to website

CRC/ TR 130 contributes to the fundamental understanding of autoimmune diseases by carrying out research into why the immune system turns on the body in certain diseases. As B cells are often the root cause in diseases which are based on autoimmune reactions, CRC/Transregio 130 is focusing its research on the antibody response to foreign bodies triggered by B cells and what goes wrong in this process in autoimmune diseases.

Go to website

The goal of CRC/Transregio 154 is to meet the challenges of energy reform using mathematical modelling, simulation and optimisation in order to provide solutions which set a new quality standard. New knowledge of various fields of mathematics, such as mathematical modelling, numerical analysis and simulation, or integer, continuous and stochastic optimisation are required to achieve this.

Go to website

The aim of CRC/TRR 241 is to better understand the interaction between cells in mucous membranes and immune cells in the bowel and to develop more effective therapy methods for chronic inflammation. During the next few years, researchers will integrate findings about the regulation and function of the immune system in the bowel and current data about anti-microbial defence on the mucous membrane barrier into a new concept. The individual projects will focus in particular on the role of misdirected communication between epithelium and immune cells during the pathogenesis of IBD. The researchers’ long-term aim is to develop medication that targets the causes of bowel inflammation while retaining the ability of the immune system to fight infections and cancer cells. In addition, they hope to find diagnostic methods that predict patients’ response to therapies – a goal that not only serves to relieve symptoms quickly, but should also contribute to lowering treatment costs.

Collaborative Research Centres involving FAU

CRC/TR 39 is working on a scientific basis which can be used to manufacture structural components in an economical way. These active systems have a broad range of potential applications, such as in mechanical and automotive engineering or in medical and automation technology. For these innovative products to be successful, new production technologies must be developed which combine manufacturing processes for mechanical components with actuator sensor modules enabling low-cost production of active components in series for the first time. CRC/Transregio ‘PT-PIESA’ has set itself this task and is working on solutions with a network of leading experts from across Germany.

Go to website

Monocrystalline superalloys are key materials in the manufacturing of turbine blades for modern gas turbines, such as those used in space technology and energy production. For this reason, they are as essential for modern society as they are for a sustainable energy supply. Using new monocrystalline technology in gas turbines increases efficiency while reducing harmful emissions – one of the main aspects of research by CRC/TR 103.

Go to website

Blood stem cell transplants are one treatment option for certain forms of leukaemia and lymph node cancer. However, in some patients immunological reactions can occur between the transplanted cells and the healthy tissue after the transplant. This often causes damage to the skin, liver and intestines. CRC/TR 221 is therefore researching the immunological mechanisms of blood stem cell transplants. The long-term aim is to increase the tolerability of this therapy and to suppress undesirable immune reactions.

Go to website

This collaborative research centre/Transregio is dealing with a new field of research where structures are generated using 3D printing in which cells and materials are arranged in structures similar to tissues. In the long term, this method could be used to create tissue models that could replace animal testing, for example. CRC/TR 225 is conducting research in the foundations of biofabrication and is investigating the behaviour of cells before and after the printing process. In addition, it is seeking to develop new materials and processes for 3D printing of tissue.

Go to website

The aim of CRC/TRR 241 is to better understand the interaction between cells in mucous membranes and immune cells in the bowel and to develop more effective therapy methods for chronic inflammation. During the next few years, researchers will integrate findings about the regulation and function of the immune system in the bowel and current data about anti-microbial defence on the mucous membrane barrier into a new concept. The individual projects will focus in particular on the role of misdirected communication between epithelium and immune cells during the pathogenesis of IBD. The researchers’ long-term aim is to develop medication that targets the causes of bowel inflammation while retaining the ability of the immune system to fight infections and cancer cells. In addition, they hope to find diagnostic methods that predict patients’ response to therapies – a goal that not only serves to relieve symptoms quickly, but should also contribute to lowering treatment costs.